-
WHO agrees on compensation plan in case of serious side effects of COVAX vaccine
expresspharma
February 23, 2021
By providing a no-fault lump-sum compensation in full and final settlement of any claims, the COVAX programme aims to significantly reduce the need for recourse to the law courts, a potentially lengthy and costly process, informed WHO.
-
AstraZeneca COVID-19 Vaccine Authorized for Emergency Use by WHO
americanpharmaceuticalreview
February 19, 2021
AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunization to prevent COVID-19 in individuals 18 years of age and older, including those over 65.
-
Africa to receive first COVID-19 vaccine doses in February
europeanpharmaceuticalreview
February 10, 2021
COVAX has allocated 90 million doses of AstraZeneca’s COVID-19 vaccine and 320,000 doses of the Pfizer-BioNTech vaccine to African countries.
-
China grants conditional approval to 2nd COVID-19 vaccine
expresspharma
February 07, 2021
China has granted conditional approval for its second COVID-19 vaccine, ahead of the expected emergency approval from the WHO for two of its jabs that would enable the country to step-up global supplies of the shots.
-
WHO-led COVID-19 probe team in China visits animal health facility
expresspharma
February 02, 2021
The independent team has already visited key hospitals, the regional disease control centre and the city’s Huanan seafood market.
-
Gavi to make 500,000 doses of Ebola vaccine available for outbreak response
europeanpharmaceuticalreview
January 25, 2021
The global stockpile will provide developing countries responding to Ebola outbreaks with doses of the approved single-dose Ebola vaccine, rVSV∆G-ZEBOV-GP, live, free of charge.
-
COVAX announces new agreement, plans for first deliveries
worldpharmanews
January 25, 2021
COVAX announced the signing of an advance purchase agreement with Pfizer for up to 40 million doses of the Pfizer-BioNTech vaccine candidate, which has already received WHO emergency use listing.
-
Computational approach shows antibiotic resistance may spread more easily than expected
europeanpharmaceuticalreview
January 22, 2021
A novel algorithm shows that there is a robust network for transferring plasmids between bacteria which may be causing the rapid spread of antibiotic resistance.
-
Unfair distribution of COVID-19 vaccines puts world on brink of ‘catastrophic moral failure’: WHO Chief
expresspharma
January 19, 2021
He said that a “me-first approach” leaves the world’s poorest and most vulnerable at risk and this will only prolong the pandemic.
-
CES 2021 MedFluid Develops First-In-Class Microfluidic Platform for Rapid Detection and Screening of Disease Diagnosis
prnasia
January 18, 2021
Health and Biotech company MedFluid has developed the fastest, first-in-class antimicrobial susceptibility test that will aid in providing precise medical prescriptions to improve the health and well-being of patients.